Endocannabinoid System Contributions to Psychiatric Risk
Authors:
- 19 June 2025
- book chapter
- Published by Springer Nature
- p. 353-383
Abstract
No abstract availableKeywords
This publication has 145 references indexed in Scilit:
- Neighborhood Resources Associated With Psychological Trajectories and Neural Reactivity to Reward After TraumaJAMA Psychiatry, 2024
- Genetic variation in endocannabinoid signaling is associated with differential network‐level functional connectivity in youthJournal of Neuroscience Research, 2021
- Cannabinoid polymorphisms interact with plasma endocannabinoid levels to predict fear extinction learningDepression and Anxiety, 2021
- Schizophrenia—An OverviewJAMA Psychiatry, 2020
- Biomarkers and Regulatory Issues2017
- Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disordersAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2016
- Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese populationMolecular Genetics & Genomic Medicine, 2014
- Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and DepressionArchives of General Psychiatry, 2012
- The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: Studies of drug use and dependence in caucasiansAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007
- The Epidemiology of Major Depressive DisorderJAMA, 2003